Last reviewed · How we verify
NCT04170387: Fibrorilax
Can a Relaxometer Improve Cognitive Impairment of Fibromyalgia Patients
NA trial testing Relaxometer in Fibromyalgia Syndrome in 40 participants. Status unknown.
15 December 2019
Quick facts
| Lead sponsor | Azienda Ospedaliera Universitaria Integrata Verona |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 15 December 2019 |
| Primary completion | 15 December 2019 |
| Estimated completion | 14 October 2020 |
Drugs / interventions tested
- Relaxometer
Conditions studied
- Fibromyalgia Syndrome — all drugs for Fibromyalgia Syndrome →
- Fibromyalgia — all drugs for Fibromyalgia →
- Pain, Chronic — all drugs for Pain, Chronic →
- Impairment — all drugs for Impairment →
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona — full company profile →
Who can join
Adults 18 to 65, any sex, with Fibromyalgia Syndrome or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the differences in cognitive performance and quality of life, after a cycle of treatment with the relaxometer, between a group of patients affected by fibromyalgia and a control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04170387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fibromyalgia Syndrome
Currently open trials in the same condition.
- NCT07327775 — Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder · recruiting
- NCT06929598 — Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents · NA · recruiting
- NCT06957873 — Craniovertebral Angle and Fibromyalgia Severity · recruiting
- NCT06539793 — Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome · NA · recruiting
- NCT05900466 — Metformin for Fibromyalgia Symptoms (INFORM Trial) · Phase 2 · recruiting
Other Azienda Ospedaliera Universitaria Integrata Verona trials
Trials by the same sponsor.
- NCT07325877 — Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis · NA · not yet recruiting
- NCT07289035 — Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. · Phase 2 · not yet recruiting
- NCT07186582 — Verona Coronary Physiology Interventional Registry · active not recruiting
- NCT06820541 — Gallbladder Stenting in FC-SEMS · NA · not yet recruiting
- NCT07338708 — Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04170387 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Universitaria Integrata Verona
- Last refreshed: 16 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing